A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K in Healthy Subjects
Clinical trial NCT02141425 · COMPLETED
Trial details
- NCT number
- NCT02141425
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-04-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.